r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

LL

Lynx1 Capital Management LP

Insider · 10% owner · KRRO

Lynx1 Capital Management LP files insider transactions with the SEC as a 10% owner of Korro Bio (KRRO). We hold 4 disclosed purchases and sales filed since 2 June 2023, 3 of them in the last 90 days.

  • Files forKRRO
  • Disclosed buys and sells4 in all, 3 in the last 90 days
  • Last disclosure13 August 2026

Positions held

5 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 31 March 2026 — 10 August 202610% owner · Korro Bio (KRRO)3 Form 4 lines · source: SEC Form 4
  • Filed 25 November 2024 — 25 June 202610% owner · Passage BIO (PASG)8 Form 4 lines · source: SEC Form 4
  • Filed 31 May 2023 — 23 December 202510% owner · TScan Therapeutics (TCRX)9 Form 4 lines · source: SEC Form 4
  • Filed 21 October 2025 — 21 October 202510% owner · Neuphoria Therapeutics (NEUP)1 Form 4 line · source: SEC Form 4
  • Filed 8 October 2025 — 17 October 202510% owner · Cullinan Therapeutics (CGEM)7 Form 4 lines · source: SEC Form 4

Everything they disclosed

28 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.